Effect of Lacosamide on the Steady-State Pharmacokinetics of Digoxin: Results from a Phase I, Multiple-Dose, Double-Blind, Randomised, Placebo-Controlled, Crossover Trial

Trial Profile

Effect of Lacosamide on the Steady-State Pharmacokinetics of Digoxin: Results from a Phase I, Multiple-Dose, Double-Blind, Randomised, Placebo-Controlled, Crossover Trial

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Apr 2014

At a glance

  • Drugs Lacosamide (Primary) ; Digoxin
  • Indications Fibromyalgia; Generalised seizures; Osteoarthritis; Pain; Partial epilepsies; Sleep disorders; Tonic-clonic epilepsy
  • Focus Pharmacokinetics
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 16 Apr 2014 New trial record
    • 15 Mar 2014 Primary endpoint 'Peak-drug-concentration' has been met.
    • 15 Mar 2014 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top